Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?

Publié en janvier 2024 Mycoses

Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study

Publication précédente

Yeast fungaemia among injection drug users in France (2012–2022): a cross-sectional observational study

Publication suivante

Auteurs

Gerard
R.
Gabriel
F.
Accoceberry
I.
Imbert
S.
Ducassou
S.
Angoso
M.
Jubert
C.